For $950 million upfront, Sobi will gain ownership to pozdeutinurad, an oral URAT1 inhibitor that performed well in Phase II ...

Fresh off a $153 million series E round, Arthrosi Therapeutics is skipping an IPO route and is instead being bought up for a ...

Gout is often blamed on overindulgence in alcohol or unhealthy eating, but research suggests genetics plays a much bigger ...

Gout, a painful joint condition, is on the rise globally, affecting even younger individuals. This surge is linked to ageing ...

The deal revolves around a drug Sobi claimed could become the “therapy of choice” for people whose gout symptoms persist ...

Sobi has signed an agreement for the acquisition of US-based biotechnology company Arthrosi Therapeutics for $950m.

Most TikTok videos inaccurately portray gout flares as a personal choice that can be alleviated through a healthy diet, ...

A new paper in Rheumatology Advances in Practice, published by Oxford University Press, indicates that TikTok videos about ...

Creators on the video platform consistently underplayed the extent to which the disease is caused by underlying factors and ...

Per the terms of the agreement, Sobi is expected to pay upwards of $950 million upfront in cash to acquire Arthrosi.The deal ...

A new paper in Rheumatology Advances in Practice indicates that TikTok videos about gout are commonly misleading, ...